Phenylpropanolamine Hydrochloride

CHEMBL1200695 Phase 4 Approuvé Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
187.7 g/mol
LogP
Phase
4

A hydrochloride salt form of phenylpropanolamine with the same therapeutic properties. A sympathomimetic drug previously used as a decongestant and appetite suppressant, though it has been largely withdrawn from the market in many countries due to an increased risk of hemorrhagic stroke.

Masse moléculaire

187,6600 g/mol

TPSA

46,30 Ų

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(N)C(O)c1ccccc1.Cl

InChI

InChI=1S/C9H13NO.ClH/c1-7(10)9(11)8-5-3-2-4-6-8;/h2-7,9,11H,10H2,1H3;1H

Molecular Formula

C9H14ClNO

HBD / HBA

3 / 2

Liaisons Rotatives

2

Atomes Lourds

12

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

A hydrochloride salt form of phenylpropanolamine with the same therapeutic properties. A sympathomimetic drug previously used as a decongestant and appetite suppressant, though it has been largely withdrawn from the market in many countries due to an increased risk of hemorrhagic stroke.

Yes, Phenylpropanolamine Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200695. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 62943. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.